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ABSTRACT Skin insult and damage start a complex healing process that involves a myriad of coordinated reactions at both
the cellular and molecular level occurring simultaneously. These processes can be divided into that of cell migration and tissue
remodeling of the wound. In addition, it is well known that deep wounds that derive from surgical procedures need a
multidisciplinary approach to have a successful wound healing process. Recently, there has been a renowned interest in the
identification of active compounds derived from ornamental, edible, and wild plants being used in the cosmetic and skin
product industry. Recent reports suggest that active components of several plants such as Propolis and Aloe vera could be used
to induce the process of wound healing and tissue regeneration and reducing therefore the time to complete wound closure.
Other plant species such as Achillea millefolium or Salvia officinalis have anti-inflammatory properties and promote cellular
proliferation contributing to faster tissue regeneration. It has been described that Malva sylvestris influences the formation of
fibrosis-free granulation tissue in the skin. Recent observations suggest that Casearia sylvestris induces the angiogenic
process. These effects have been evaluated in cell lines, different animal models, and some in randomized clinical trials. In
this review we summarize the evidence of plant extracts and their active components (when known) in the acceleration of the
wound closure process and tissue repair.
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INTRODUCTION
Skin is a fibroelastic membrane. It is an important or-gan that protects us from external insult,1 provides the
means for thermal regulation,2 protects us from ultraviolet
radiation insult, and participates in the production of vitamin
D.3 In addition, it is also a physical barrier fending off
against infectious insults as part of the innate immune sys-
tem.4 Skin is the biggest organ of the human body and the
most important receptor of input from the surrounding
world.5 The skin comprises two main layers as follows: the
dermis and epidermis. The epidermis is the most external
layer; it has no blood vessels and acts as a barrier preventing
moisture loss and as a physical barrier against infection.6
Given the exposure of this barrier to physical, chemical,
or thermal exposure it is susceptible to integrity damage.7 In
cases of integrity loss of such barrier the skin must be re-
stored and for such tasks several processes must be under-
taken to restore the skin to its normal functions.8 This event
of restoration of the skin homeostasis is known as wound
healing, and its ultimate goal is to maintain the barrier in-
tegrity. It involves a series of complex interactions between
different cell types, growth factors, chemokines and cyto-
kines, enzymes, and extracellular matrix (ECM) compo-
nents.9
The wound closure process involves several sequential
steps that are triggered by vasoactive molecules that produce
a domino effect of several autocrine, paracrine, and endo-
crine signals10;
(a) Coagulation or hemostasis; starts by the formation of
a thrombus, which protects the wound and provides a
provisional ECM for the formation of new tissue,11,12
(b) Inflammation; mediated by several pro-inflammatory
mediators such as thromboxanes, prostaglandins, and
substance P, among others. This causes the release of
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cytokines and chemokines, as well as the infiltration of
neutrophils and macrophages that eliminate the debris
of dying cells by phagocytosis12 of such debris and
also the elimination of microorganisms from the
wound,13
(c) Proliferation; (promoting granulation tissue forma-
tion and collagen synthesis).14 The cells in the sur-
rounding area of the wound start to proliferate and
increase their mitotic activity due to several growth
factors such as transforming growth factor-b, platelet-
derived growth factor, keratinocyte growth factor,
vascular endothelial growth factor, among others15
which are being secreted at the site by macrophages
and fibroblasts.12,16 The angiogenesis and formation of
new blood vessels are paramount for the tissue re-
generation. In addition, the migration of fibroblasts and
the remodeling of fibrin, vitronectin, and fibronectin by
the migrating cells initiate the process of remodeling of
the wound. After this the formation of the permanent
ECM composed of type I, III, and V collagen, pro-
teoglycans, and others is synthesized. In order for this
process to happen several matrix metalloproteinases
(MMPs) are secreted and contribute to the degradation
of the damaged tissue.15 At the same time there is
migration of keratinocytes to the wound center in the
reepithelialization process that cause the wound con-
traction in the edges.16
(d) Remodeling that determines the strength and ap-
pearance of the scarring tissue.1 During this phase,
most of the cells that were active in the proliferation
phase die by apoptosis. The MMPs increase their ac-
tivity given that the granulation tissue production has
ceased. It is important to mention that this new tissue
does not have the same characteristics as the granula-
tion tissue; it shows a higher rigidity and exhibits a
lower elasticity and flexibility due to a higher content
of type I collagen and the lack of elastin.15,16
The successful healing of the wound when both the der-
mis and epidermis have been compromised depends on
several intrinsic factors such as the production of reactive
oxygen species (ROS),17 lactate,18 hypoxia inducible fac-
tors,19 as well as of extrinsic factors such as medication,20
emotional stress,21 nutrition,22 age,10 and so on.
Throughout history, different attempts and approaches
were used to cure wounds in ancient times23 and till today it
is an important matter of research worldwide. In such an-
cient times it was understood that the use of the correct
compounds from nature would lead to wound closure.24
Continuing with this line of reasoning a continuous expan-
sion and a better understanding of the intrinsic and extrinsic
factors that govern wound healing have been described.
Despite the discovery of antimicrobial agents, antiseptics,
and anti-inflammatory drugs, the wound closure process is
challenging in the clinical setting of modern medicine.
Plants and natural extracts that have been used in tradi-
tional medicine are considered as potential agents for the
prevention and treatment of superficial lesions of the skin,
and evidence of efficacy in the clinical setting is growing
rapidly. In this context this review summarizes the evidence
of such plant derivatives and their use in wound healing.
PLANTS WITH POSITIVE EFFECTS
IN WOUND CLOSURE
Achillea millefolium
This plant of the Achillea genus that belongs to the As-
teraceae family is a herb and from its rhizome arises one or
various stems with rare ramifications. It is characterized
morphologically by the way in which the five ligules are
grouped visualizing themselves as a single flower. The name
of the genus is originated from the Greek mythology
‘‘Achilles.’’ The Greek hero apparently used this herbal
remedy for his injured heel. Other species of Achillea have
been used in other medicinal purposes for thousands of
years.25 Achillea millefolium is used in several therapeutic
and pharmacologic applications: in water through the oral
route as a stimulating tonic,26 astringent,27 spasmolytic,28
and choleretic.29 When used as a topical in the skin it has
anti-inflammatory and healing properties.30 It has been de-
scribed that in the essential oil derived from the dried
flowers and obtained by distillation it contains azulen. It has
also been used in hemostasis to stop bleeding,31 in menstrual
cramps,32 and in the treatment of gastric disorders (diarrhea)
and has been demonstrated to also be useful in the gastro-
intestinal tract due to its antispasmodic activity.28 Hepatic-
protective effects have also been reported.33 In 2015 Agar
et al.34 evaluated the antioxidant, wound closure, and cy-
totoxic compounds from Achillea and observed a strong
ROS scavenging and detoxifying activity with a high
binding capacity (EC50 = 32.63 – 0.65 g/mL, P > .05) con-
firming their antioxidant activity. The anti-inflammatory
effects of A. millefolium extract are mediated by the activity
of such compounds on the arachidonic acid metabolism.35
To evaluate the healing effect of Achillea at the cellular
level, mice derived fibroblasts were used. When the cells
were treated with the plant extract a clear proliferating ef-
fect was observed, as well as an increased production of
type I collagen, which would accelerate healing. A low
level of cytotoxicity was also shown.34 Another study that
used the fibroblast Hs68 cell line and the keratinocyte Ha-
CaT cells treated with extract from A. asiatica (pertaining
to a related species to A. millefolium) showed a strong anti-
inflammatory activity by reducing nitric oxide produc-
tion and release of prostaglandin E2. In addition, a reduced
expression of tumor necrosis factor-a, interleukin (IL)-1b,
IL-6, and cyclooxygenase-2 was observed. The authors ob-
served that an increased wound healing promotion and in-
creased expression of differentiation markers (b-catenin) in
HaCaT cells and also in a model of wound healing in Sprague-
Dawley rats were treated with A. millefollium extract.36
The effects of Achillea species on in vivo wound healing
have also been evaluated in mice and rat models. A study by
Akkol et al.37 in 2011 showed that Achillea extracts com-
pared to Madecassol (wound healing cream) indicated that





















































the extract had a better effect on wound healing and closure
compared to the control. The data clearly showed that the
treated animals had a higher activity in inducing wound
healing than the reference drug.37
Recently, A. millefolium has been tested in clinical trials.
In a study performed in pregnant women (first pregnancy) of
Iranian descent, the wound healing and anesthetic effect
were evaluated during the episiotomy recovery phase. It was
shown that the extract of this plant showed a significant
reduction of perianal pain, as well as redness, edema, and
hematomas around the wound.38 In this study the authors
recommend the use of the extract of this plant in a com-
mercial cream preparation for the treatment of these kinds of
wounds. Until now no adverse effects have been reported on
the use of A. millefolium extract or any of its compounds, so
it can be considered as a viable option for the treatment of
episiotomy wounds.
Malva sylvestris
Malva sylvestris is a plant that shows pubescent stems of
80 cm long, and in some cases even bigger species have been
found. The leaves are round and hepta lobulated with small
fibrils in the leaf and nerves. The plant flowers in summer
and are hermaphroditic of 6 cm in diameter. The flowers are
violet with nerves in a reddish color. As a fruit this plant has
a capsule or nutlet containing several structures with seeds
in each of these that serve as a spreading mechanism.39
There are many species of M. sylvestris (Malvaceae)
being used in the popular medicine. Pre-Christian era use of
the plant has been documented both for consumption and
medicinal purposes.35 Nowadays, the consumption of M.
sylvestris has extended due to description of anticarcino-
genic and anti-inflammatory properties,40,41 antioxidant
properties,42 and skin wound healing properties.43 Recently
a study by Afshar et al.44 evaluated the wound healing effect
of M. sylvestris in a Balb/c experimentally induced skin
injury model. The authors describe that those animals trea-
ted with silver sulfadiazine (SSD) and the vehicle were less
able to induce wound healing than M. sylvestris. It induced
granulation tissue and reepithelialization. In addition, the
synthesis of collagen was also increased.44
In another in vivo study using a model of second-degree
burn (under anesthesia), the authors compared the effect on
wound healing of animals treated with M. sylvestris or SSD.
The results clearly show that the cream with M. sylvestris
show a shorter time for wound healing than sulfadiazine,
reducing the time to complete wound healing by 10 days.45
The data suggest the possibility of using M. sylvestris for
clinical use for such indications, although the molecular
mechanism behind such effects remains the matter of further
investigation.
Salvia sp.
It is a herbal medicine with flowers resembling a blue
floral array. It flowers at the end of spring and until almost
the end of summer. It usually grows in plains and near
farmland and not in highly humid or watery zones. The
genus of Salvia is the biggest and most important one of the
Lamiaceae family; it has around 900 species spread
throughout the world, including several ornamental, edible,
and medicinal species.46 The Salvia has been used ances-
trally as a medicine for different diseases such as reducing
nocturnal sweating and to normalize menstrual and hor-
monal functions in women.47 It has some hypoglycemic
properties, and some one species like S. miltiorrhiza has
been also used as a wound-healing agent.46,48 The published
data suggest that several species of Salvia exert various
biological activities and have been used around the world as
a traditional medicine approach to several diseases. Its uses
include antioxidant,49 antimicrobial,50 anti-inflammatory,51
pain relief,52 antipyretic,53 hemostatic,52 hypoglycemiant,54
antitumor,55 and wound healing inducer.56
In a study performed by Liang et al.,57 it was showed that
the effects of this S. miltiorrhiza act as an inhibitor of
MMPs. These enzymes play an important role in the wound
healing process and are also involved in the inflammatory
response regulation through extracellular matrix remodeling
and in the migration of immune cells.58 However, the ex-
cessive or unregulated activity of MMP contributes to the
development of chronic nonhealing wounds.59 Therefore, it
is of great importance that compounds of this plant regulate
the activity of MMPs. This was evaluated using rat neu-
trophils as a source of MMP1, 3, and 9 for such assays. It
was shown that MMP-1, MMP-2, and MMP-9 are inhibited
by Salvia extracts.57 Therefore, there is evidence that such
compounds could be used to modulate wound healing
through modulation as active ingredients of formulations for
wound healing or cosmetics.
Recent data support that nociception and anti-
inflammatory effects of S. officinalis of both the aqueous and
organic (butanolic) extracts of the plant show in vivo effects
in mice. The authors used the hot plate model and also in the
formalin and carrageenan model and was shown to reduce
the inflammation.60 Although several studies are still un-
derway to fully characterize the effects of S. officinalis on
wound healing and other potential clinical applications, the
landscape looks promising for its use in wound healing and
skin inflammatory diseases.
Casearia sylvestris
Casearia sylvestris is a tree belonging to the Salicaceae
family. It is a small bush 4–6 m in height with elongated
branches. Leaves are simple and alternated with an acumi-
nated apex and indented margins. In the inverse the nerves
are prominent. It produces small flowers in a creamy white
color with a strong aroma resembling honey and uric acid.
The flowers are presented in bunches or clusters. The tree
flowers in July, these flowers remain until October, and the
fruit is fully developed from September to December. After
flowering, which can occur in the second year of life of the
plant, small green and round fruit appears from 3 to 4 mm in
diameter to become a fully mature red and orange fruit with
three seeds in a pale brown color.61 This plant can be found
in the forests of Mexico and also in the Brazilian territory.





















































The hydroalcoholic extract obtained from the leaves of the
plant contains a variety of chemicals among which we find:
Diterpenes, triterpenes, hexanoic acid, caproic acid, etc.62,63
In ethnopharmacology several plants with anti-
inflammatory and wound healing properties have been used.
An example of such plant is C. sylvestris.64 Some reports on
C. sylvestris describe the use of such plants in the treatment
of skin lesions and small ulcerations in the skin.65 Studies of
this plant have demonstrated its pharmacological, analgesic,
and anti-inflammatory properties.66,67 de Mattos et al. in
2007 suggested that it could be used in conditions associated
with chronic pain management.68 Recently in 2015, de
Campos et al.,69 evaluated the wound healing effects of this
plant in a burn-wound induction model in rat and mice. The
extract of the plant was compared to saline, and the authors
found an important antioxidant effect, as well as antiseptic
and anti-inflammatory activity. It also accelerates the wound
healing process, which reduces tissue damage and improves
capillary permeability.69 These pharmacological features of
the extract suggest a potential and beneficial therapeutic
effect of this plant to be used in inflammatory diseases and
in wound healing.
NATURAL EXTRACTS WITH WOUND HEALING
ENHANCING/HEALING PROPERTIES
Propolis
Propolis is a resinous substance collected in the hind legs
of Apis mellifera from plants, salivary enzymes, plant exu-
dates, etc. It is composed mainly from resins (50%) vege-
table oil (10%), bee wax (30%), essential oil (10%), pollen
(5%), and other organic compounds.70,71 Propolis has been
used since ancient times for several diseases and applica-
tions.72 The Egyptians used it for corpse embalming and to
avoid flesh putrefaction. In addition, the Incas used it as an
antipyretic agent.72,73 Greek physicians used it as an anti-
septic and for topical use in superficial wounds and in the
mucosal surfaces.74 Propolis was classified as an official
drug in the pharmacopeias of the XVII century in London. In
addition, due to the antibacterial activity it was widely used
in the XVII and XX centuries.75 The biological effects of
propolis are, in part, mediated by flavonoid compounds
terpene, caffeic acid, phenolic acid, and several ester com-
pounds.76
Nowadays, propolis is a natural therapeutic commercially
available in several topical presentations and is used for the
treatment of infectious diseases in human and veterinary
medicine. In addition, applications in cosmetology and
pharmacology have been derived from this mixture of active
compounds.70 Several formulations are in the market for the
treatment of the upper respiratory tract, common cold, and
flu.77 The dermatology community uses of propolis include
wound healing burn treatment,78 acne,70 herpes infection,
and genitourinary infections79; it has also been used for the
treatment of several types of dermatological disease such as
neurodermatitis.80
There is a wide variety of propolis depending on the
vegetation of the recollection zone. One of the most studied
mixtures is the red propolis of Brazil; the characteristic red
color of this mixture is due to Dalbergia ecastaphyllum
colored compounds.81 In a study of the wound healing ef-
fects with this BRPE or Brazilian Red Propolis Extract that
contained a high amount of polyphenol compounds, it was
found that the animals that were treated with BRPE showed
a significant reduction of the lesion area. In addition, in
histological and immunohistochemical studies it was found
that the number of neutrophils infiltrating the tissue was
reduced compared to control animals. In the same manner it
was shown that the transcription factor p-NF-jB showed a
significant reduction in the animal’s tissues treated with the
propolis, as well as the production of pro-inflammatory
cytokines. Therefore the authors provide evidence of the
effects of this mixture on the wound healing process.82
In a study by Jacob et al.,83 it was shown that the effects
of propolis on fibroblast cell line could be useful in the
wound healing process. In the study, the authors show that
10–100 mg/mL of the extract shows effects by increasing
the migration and proliferation of these cells.83 In another
study the effect of propolis in wound healing was evaluated
in the formation and metabolism of fibronectin and its ef-
fects in the formation of ECM. It was shown that there was
an improvement in the formation of the granulation tissue
which is a hallmark of the wound healing process.84
In another report of propolis on the effect of wound
healing in an experimental wound model in dogs, it was
reported that topically administered propolis induced a re-
duction of 30% in the wound area compared to control and
also a reduction in the time needed for complete healing.85
In addition, in similar models, it has been demonstrated to be
safe, effective, and cheap; therefore, it could be considered
as a viable option for the treatment of wound lesions.86
Recent studies have analyzed the effect of propolis. In
2014, Henshaw et al.,87 evaluated the wound healing effect
of propolis in diabetic ulcer wounds in humans. The patients
received a topical administration of a product based in
propolis in the wound for 6 weeks. The percentage of healed
wound was photographically analyzed, and the areas of
wound closure were compared to the control group that was
treated with conventional antibiotics therapy. The wound
area was reduced 41% compared to the control group. In
addition, the authors evaluated the activity of metallopro-
teases 2 and 9 that were significantly elevated in the chronic
wounds.87 These observations indicate that MMP-9 corre-
lates with wound healing and with the production of colla-
gen. The results of this report suggest that propolis improves
wound healing compared to the standard of care and, addi-
tionally, provides evidence that such treatment is well tol-
erated in the clinical setting. In similar settings, other studies
have reported a reduction in ulcer size during the first 2
weeks of treatment compared to standard of care.88
The effect of propolis has also been studied in a synergic
model of honey treatment in which it was shown that in an
animal model the effects of propolis are potentiated by the
use of honey and accelerating the wound healing process,
shortening the time to complete wound closure, and in-
creasing angiogenesis and granulation tissue formation.89,90














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Aloe vera produces a mucilaginous gel in the parenchy-
mal cells of the pulp of the plant of A. badensis. It is a
peroneus plant pertaining to the Liliaceae family. In the
traditional medicine of various indigenous populations, this
plant has been used for the treatment of wounds as an ad-
juvant to wound healing and other skin diseases. Several
reports indicate that A. vera has been used mainly for several
conditions, such as wound healing, healing of burn wounds,
immunomodulation, anti-inflammatory, and hypoglycemic
(antidiabetic). A. vera is used commercially in several
products such as sunburn cream, cosmetics, and lotions. The
components of A. vera derived gels contain several poly-
saccharides, amino acids, lipids, and sterols, as well as
tannins and enzymes.91,92 These extracts are used, and the
nature and properties of the different components in the
mixture had not been fully characterized. Therefore it has
been suggested that the individual compounds need to be
isolated and fully characterized to elucidate the mechanism
of action of the A. vera gel mixture.93 In vitro, these com-
ponents together with the mixture have been shown to in-
duce the proliferation of several cell lines, and it has been
fully characterized that the treatment induces a faster wound
healing compared to the control94,95; this was shown in an
animal model of wound healing in diabetic and nondiabetic
Wistar rats. Some reports have also provided evidence that
the effects of A. vera could be mediated by the effects on the
immune system, particularly on the activation of macro-
phages.96–99 Despite the wide use of this plant in wound
healing in the popular medicine of several countries, the
mechanism of action has not been fully understood.
In a study by Tabandeh et al.,100 the authors evaluate the
effect of polysaccharides purified from A. vera in Wistar rats.
The animals underwent a biopsy punch–induced wound, and
the isolated polysaccharides were applied topically to the
wound. At later times biopsies of the healed and scarring
tissue were obtained to analyze gene expression of MMP-3
and the inhibitor tissue inhibitor of metalloproteinases 2
(TIMP-2). The results suggest that the A. vera treated animals
showed a faster wound closure and that the expression of
MMP-3 was increased during the first 10–20 days post-
wound. The data also suggested that this improved wound
healing was associated with a reduced expression of MMP-3
induced by the treatment. The authors conclude that the A.
vera derived polysaccharides are able to regulate the ex-
pression of MMP-3 and TIMP-2 and that this event of gene
expression regulation is partially responsible for the im-
proved formation of granulation tissue and therefore for the
wound healing effects and the formation of ECM proteins.100
A report by Khan et al.,101 also suggest that the topical
application of A. vera gel in a Wistar rat model of wound
healing improved the wound closure compared to an un-
treated group. The authors also evaluated several markers of
macrophage activation and the proliferation activity of fi-
broblasts and collagen synthesis.101
Another component of A. vera is the sterols: Lophenol and
Cycloartenol. These have reported effects on body fat com-
position, alterations in glycemia, and lipid metabolism in an-
imal models of diabetes and obesity.102 In addition, it has been
reported that in vitro, these sterols have effects on the mRNA
profiles of primary culture fibroblasts, mainly in those asso-
ciated with collagen and hyaluronic acid synthesis.103 In the
clinical setting, a double-blind randomized trial of advanced
age women of Japanese descent evaluated the oral adminis-
tration of an extract of A. vera on the depth of facial wrinkles
and also in the retention of humidity in the facial and forearm
skin. The results suggest that sterols derived from A. vera have
effects on the expression of COLA31 mRNA in fibroblasts.
The authors suggest that by the stimulation of hyaluronic acid
synthesis in fibroblasts a higher retention of humidity and,
therefore, a reduced depth of wrinkles in women is mediated
by moisture retention.103 The effects of these sterols highlight
the participation of such compounds on the remodeling phase
of the wound healing process. Such knowledge could be used
to improve the esthetics of the wounds. Further research is
needed on this matter to better understand the underlying
mechanisms of A. vera’s wound healing properties. All of the
aforementioned data is summarized in Table 1.
CONCLUDING REMARKS
The wound healing process requires support in three key
events. In the first place the absence of infection; second,
the stimulation of repair mechanisms to promote cell mi-
gration, cell to cell adhesion, and improving tensile strength
of the skin to improve elasticity and moisturizing properties
of the skin. And third, the nutritional, anti-inflammatory,
antiseptic, and antimicrobial effects needed for complete
wound closure. As shown throughout the review, all of
these processes are promoted to a certain extent by the
plants or extracts that were described. Besides, the tradi-
tional use of these extracts allows for the clinical use of
such plants to be further characterized in the clinical set-
tings. The extracts and plants that are currently used have
several active compounds and biomolecules that have been
characterized as the ones responsible for the effects ob-
served in wound healing and burn wounds. Further research
is needed to fully characterize such effects and the active
compounds responsible for such biological effects. How-
ever, nowadays, strong evidence supports the use of such
plant extracts on the wound healing process. It is of great
importance that individual compounds are tested to ac-
knowledge and identify toxic or side effects and potentiate
the observed beneficial effects of such mixtures of com-
pounds. This will ultimately lead to pharmaceutical use of
individual compounds with broadly characterized effects
and security profiles for wound healing.
AUTHOR DISCLOSURE STATEMENT
No competing financial interests exist.
REFERENCES
1. Guarı́n-Corredor C, Quiroga-Santamarı́a P, Landı́nez-Parra NS:
Healing process of skin wounds, endogenous fields and their





















































relationship with chronic wounds [In Spanish]. Rev Facult Med
2013;61:441–448.
2. Romanovsky AA: Skin temperature: Its role in thermoregula-
tion. Acta Physiol (Oxf) 2014;210:498–507.
3. Holick MF: Ultraviolet B radiation: The vitamin D connection.
Adv Exp Med Biol 2017;996:137–154.
4. Levin C, Perrin H, Combadiere B: Tailored immunity by skin
antigen-presenting cells. Hum Vaccin Inmunother 2015;11:
27–36.
5. Baum CL, Arpey CJ: Normal cutaneous wound healing: Clin-
ical correlation with cellular and molecular events. Dermatol
Surg 2005;31:674–686; discussion 686.
6. Kubo A: [Structural and immunological barriers of the skin as
potential therapeutic targets]. Yakugaku Zasshi 2014;134:623–
627 (Article in Japanese).
7. Chen D, Hao H, Fu X, Han W: Insight into reepithelialization:
How do mesenchymal stem cells perform? Stem Cells Int 2016;
2016:6120173.
8. Singh M, Govindarajan R, Nath V, Rawat AK, Mehrotra S:
Antimicrobial, wound healing and antioxidant activity of Pla-
giochasma appendiculatum Lehm. et Lind. J Ethnopharmacol
2006;107:67–72.
9. Kumar B, Vijayakumar M, Govindarajan R, Pushpangadan P:
Ethnopharmacological approaches to wound healing—ex-
ploring medicinal plants of India. J Ethnopharmacol 2007;114:
103–113.
10. Diegelmann RF, Evans MC: Wound healing: An overview of
acute, fibrotic and delayed healing. Front Biosci 2004;9:283–
289.
11. Guo S, DiPietro LA: Factors affecting wound healing. J Dent
Res 2010;89:219–229.
12. Flanagan M: The physiology of wound healing. J Wound Care
2000;9:299–300.
13. Turksen K: Wound Healing: Stem Cells Repair and Restora-
tions: Basic and Clinical Aspects. Wiley, Hoboken, NJ, 2018.
14. Joao De Masi EC, Campos AC, Joao De Masi FD, et al.: The
influence of growth factors on skin wound healing in rats. Braz
J Otorhinolaryngol 2016;82:512–521.
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50. González AG, Abad T, Jiménez IA, et al.: A first study of
antibacterial activity of diterpenes isolated from some Salvia
species (Lamiaceae). Biochem Syst Ecol 1989;17:293–296.
51. Rodrigues MR, Kanazawa LK, das Neves TL, et al.: Anti-
nociceptive and anti-inflammatory potential of extract and iso-
lated compounds from the leaves of Salvia officinalis in mice.
J Ethnopharmacol 2012;139:519–526.
52. Hosseinzadeh H, Haddadkhodaparast MH, Arash AR: Anti-
nociceptive, antiinflammatory and acute toxicity effects of
Salvia leriifolia Benth seed extract in mice and rats. Phytother
Res 2003;17:422–425.
53. Peng MM, Fang Y, Hu W, Huang Q: The pharmacological
activities of compound Salvia plebeia granules on treating uri-
nary tract infection. J Ethnopharmacol 2010;129:59–63.
54. Alarcon-Aguilar FJ, Roman-Ramos R, Flores-Saenz JL,
Aguirre-Garcia F: Investigation on the hypoglycaemic effects of
extracts of four Mexican medicinal plants in normal and
alloxan-diabetic mice. Phytother Res 2002;16:383–386.
55. Liu J, Shen HM, Ong CN: Salvia miltiorrhiza inhibits cell
growth and induces apoptosis in human hepatoma HepG(2)
cells. Cancer Lett 2000;153:85–93.
56. Chen YS, Lee SM, Lin YJ, Chiang SH, Lin CC: Effects of
danshensu and salvianolic acid B from Salvia miltiorrhiza
Bunge (Lamiaceae) on cell proliferation and collagen and
melanin production. Molecules 2014;19:2029–2041.
57. Liang YH, Li P, Huang QF, Zhao JX, Liu X, Dai MK:
Salvianolic acid B in vitro inhibited matrix metalloproteinases-
1, -2, and -9 activities. Zhong Xi Yi Jie He Xue Bao 2009;7:145–
150.
58. Ricard-Blum S, Vallet SD: Proteases decode the extracellular
matrix cryptome. Biochimie 2016;122:300–313.
59. Xue M, Le NT, Jackson CJ: Targeting matrix metalloproteases
to improve cutaneous wound healing. Expert Opin Ther Targets
2006;10:143–155.
60. Qnais EY, Abu-Dieyeh M, Abdulla FA, Abdalla SS: The anti-
nociceptive and anti-inflammatory effects of Salvia officinalis
leaf aqueous and butanol extracts. Pharm Biol 2010;48:1149–
1156.
61. Malaret A: Lexicon of Fauna and Flora [In Spanish]. 6a ed.
Permanent Commission of the Association of Academy of
Spanish Language, Madrid, Spain, 2003.
62. Oberlies NH, Burgess JP, Navarro HA, et al.: Novel bioactive
clerodane diterpenoids from the leaves and twigs of Casearia
sylvestris. J Nat Prod 2002;65:95–99.
63. Espindola LS, Vasconcelos Junior JR, de Mesquita ML, et al.:
Trypanocidal activity of a new diterpene from Casearia syl-
vestris var. lingua. Planta Med 2004;70:1093–1095.
64. Bahramsoltani R, Farzaei MH, Rahimi R: Medicinal plants and
their natural components as future drugs for the treatment of
burn wounds: An integrative review. Arch Dermatol Res 2014;
306:601–617.
65. Lipinski LC, Wouk AF, da Silva NL, Perotto D, Ollhoff RD:
Effects of 3 topical plant extracts on wound healing in beef
cattle. Afr J Tradit Complement Altern Med 2012;9:542–547.
66. Esteves I, Souza IR, Rodrigues M, et al.: Gastric antiulcer and
anti-inflammatory activities of the essential oil from Casearia
sylvestris Sw. J Ethnopharmacol 2005;101:191–196.
67. Da Silva SL, Chaar Jda S, Yano T: Chemotherapeutic potential
of two gallic acid derivative compounds from leaves of Case-
aria sylvestris Sw (Flacourtiaceae). Eur J Pharmacol 2009;608:
76–83.
68. de Mattos ES, Frederico MJ, Colle TD, et al.: Evaluation of
antinociceptive activity of Casearia sylvestris and possible
mechanism of action. J Ethnopharmacol 2007;112:1–6.
69. de Campos EP, Trombini LN, Rodrigues R, et al.: Healing
activity of Casearia sylvestris Sw. in second-degree scald burns
in rodents. BMC Res Notes 2015;8:269.
70. Wagh VD: Propolis: A wonder bees product and its pharma-
cological potentials. Adv Pharmacol Sci 2013;2013:308249.
71. Burdock GA: Review of the biological properties and toxicity
of bee propolis (propolis). Food Chem Toxicol 1998;36:347–
363.
72. Viuda-Martos M, Ruiz-Navajas Y, Fernández-López J, Pérez-
Alvarez JA: Functional properties of honey, propolis, and royal
jelly. J Food Sci 2008;73:R117–R124.
73. Kuropatnicki AK, Szliszka E, Krol W: Historical aspects of
propolis research in modern times. Evid Based Complement
Alternat Med 2013;2013:964149.
74. Bankova VS, de Castro SL, Marcucci M: Propolis: Recent ad-
vances in chemistry and plant origin. Apidologie 2000;31:3–15.
75. Monti M, Berti E, Carminati G, Cusini M: Occupational and
cosmetic dermatitis from propolis. Contact Dermatitis 1983;9:
163.
76. Berretta AA, Nascimento AP, Bueno PC, Vaz MM, Marchetti
JM: Propolis standardized extract (EPP-AF(R)), an innovative
chemically and biologically reproducible pharmaceutical com-
pound for treating wounds. Int J Biol Sci 2012;8:512–521.





















































77. Khosravi AR, Shokri H, Nikaein D, et al.: Yeasts as important
agents of onychomycosis: In vitro activity of propolis against
yeasts isolated from patients with nail infection. J Altern
Complement Med 2013;19:57–62.
78. Jastrzebska-Stojko Z, Stojko R, Rzepecka-Stojko A, Kabala-
Dzik A, Stojko J: Biological activity of propolis-honey balm in
the treatment of experimentally-evoked burn wounds. Mole-
cules 2013;18:14397–14413.
79. Huleihel M, Isanu V: Anti-herpes simplex virus effect of an
aqueous extract of propolis. Isr Med Assoc J 2002;4(11 Suppl):
923–927.
80. Khachaturov AA, Gudkov AI: [Propolis therapy of certain
dermatoses and burns in the far north]. Vestn Dermatol Venerol
1969;43:63–65 (Article in Russian).
81. Daugsch A, Moraes CS, Fort P, Park YK: Brazilian red prop-
olis—chemical composition and botanical origin. Evid Based
Complement Alternat Med 2008;5:435–441.
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